Li Lin

4.3k total citations
122 papers, 3.4k citations indexed

About

Li Lin is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Li Lin has authored 122 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 22 papers in Neurology and 18 papers in Immunology. Recurrent topics in Li Lin's work include Fibroblast Growth Factor Research (27 papers), Epigenetics and DNA Methylation (17 papers) and Neuroinflammation and Neurodegeneration Mechanisms (16 papers). Li Lin is often cited by papers focused on Fibroblast Growth Factor Research (27 papers), Epigenetics and DNA Methylation (17 papers) and Neuroinflammation and Neurodegeneration Mechanisms (16 papers). Li Lin collaborates with scholars based in China, United States and South Korea. Li Lin's co-authors include Xiaokun Li, Jian Xiao, Hongyu Zhang, Jian Hu, Xiaoying Wang, Zhanyang Yu, Xiaojie Wang, Ye Xiong, Liyun Zhu and Litong Jin and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Li Lin

116 papers receiving 3.4k citations

Peers

Li Lin
Comparison fields: 5 of 140
  • Molecular Biology 1.4k
  • Neurology 612
  • Cellular and Molecular Neuroscience 396
  • Physiology 349
  • Immunology 339
Replace Srinivasulu Chigurupati with:
Srinivasulu Chigurupati United States
M. Francesca Cordeiro United Kingdom
Mei Zhao China
Gholamreza Hassanzadeh Iran
Arabinda Das United States
Michela Campolo Italy
Marina S. Hernandes United States
Dariusz C. Górecki United Kingdom
Kui Xu United States
Xia Qin China
Srinivasulu Chigurupati United States View profile →
Citations per field, relative to Li Lin
Li Lin · 1×
Citations per year, relative to Li Lin
Li Lin · 1×

Countries citing papers authored by Li Lin

Since Specialization
Citations

This map shows the geographic impact of Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lin more than expected).

Fields of papers citing papers by Li Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lin. The network helps show where Li Lin may publish in the future.

Co-authorship network of co-authors of Li Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Li Lin. A scholar is included among the top collaborators of Li Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Lin. Li Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 11
3 4
4 13
5 10
6 11
7 1
8 16
9 3
10 31
11 6
12 11
13 27
14 51
15 31
16 14
17 91
18 52
19 19
20 48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026